- Home
- GRVY vs AQST Comparison
GRVY vs AQST Comparison
Compare GRVY & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRVY | AQST |
|---|---|---|
| Founded | 2000 | 2004 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 426.5M | 504.0M |
| IPO Year | 2005 | 2007 |
Fundamental Metrics
Financial Performance| Metric | GRVY | AQST |
|---|---|---|
| Price | $56.81 | $4.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 63.3K | ★ 1.5M |
| Earning Date | 05-08-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,430,000.00 |
| Revenue This Year | N/A | $10.08 |
| Revenue Next Year | N/A | $49.60 |
| P/E Ratio | $8.05 | ★ N/A |
| Revenue Growth | N/A | ★ 0.77 |
| 52 Week Low | $54.54 | $2.94 |
| 52 Week High | $74.75 | $7.55 |
Technical Indicators
Market Signals| Indicator | GRVY | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 36.20 | 55.06 |
| Support Level | $55.89 | $3.95 |
| Resistance Level | $59.64 | $4.38 |
| Average True Range (ATR) | 2.36 | 0.15 |
| MACD | -0.57 | 0.03 |
| Stochastic Oscillator | 9.06 | 82.22 |
Price Performance
Historical ComparisonAbout GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.